bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Atara Biotherapeutics Inc. logo

    Atara Biotherapeutics Inc.

    ATRA | NASDAQ
    Chart Builder DCF Calculator
    $8.01
    -$0.52 (-6.10%)
    At close: Oct 30, 2026, 4:00 PM ET
    $8.01
    $0.00 (0.00%)
    Pre-market: Nov 2, 2026, 8:54 AM ET

    Market Data

    Market Cap
    $80.4M
    Enterprise Value
    $80.41M
    Beta
    0.09
    Average Volume
    50.82K
    Shares Outstanding (Diluted)
    15.03M
    Shares Change YoY
    22.12%
    Institutional Ownership
    29.72%
    Exchange
    NASDAQ
    ISIN
    US0465132068

    Price Performance

    Price Change 1M
    -5.8%
    Price Change 3M
    -4.4%
    Price Change 6M
    63.5%
    Price Change YTD
    -55.7%
    Price Change 1Y
    -46.1%
    Price Change 3Y
    -75.2%
    Price Change 5Y
    -97.9%
    1M CAGR (ann.)
    -17.3%
    1Y CAGR (ann.)
    -43.0%
    5Y CAGR (ann.)
    -54.3%
    All-Time CAGR
    -31.5%

    Valuation

    PE Ratio
    -6.79
    Forward PE
    6.72
    PEG Ratio
    0.05
    Forward PEG
    0.05
    PS Ratio
    12.98
    Forward PS
    1.80
    PB Ratio
    -2.17
    P/FCF Ratio
    -3.67
    P/Adj. FCF Ratio
    -3.12
    P/OCF Ratio
    -5.49
    EV/Sales
    12.98
    EV/EBIT
    -5.81
    EV/EBITDA
    -5.89
    EV/FCF
    -3.67
    Earnings Yield
    -14.7%
    FCF Yield
    -27.2%
    Adj. FCF Yield
    -32.1%

    Financial Health

    Net Cash
    $9.87M
    Total Debt
    $9.88M
    Cash & Short-Term Investments
    $9.87M
    Total Assets
    $21.02M
    Current Ratio
    1.98
    Quick Ratio
    1.98
    Debt / Equity Ratio
    -0.27
    Debt / EBITDA
    -0.72
    Debt / FCF
    -0.45
    OCF / Debt
    -2.22
    Interest Coverage
    -5.04
    Altman Z-Score
    -135.90
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    91.4%
    Operating Profit Margin
    -229.7%
    EBITDA Margin
    -221.3%
    Net Profit Margin
    -269.4%
    FCF Margin
    -353.5%
    Adj. FCF Margin
    -416.2%
    SBC / Revenue
    62.7%
    SBC Impact (per share)
    -17.7%

    Returns

    Return on Assets
    -79.4%
    Return on Equity
    44.7%
    Return on Invested Capital
    -93.1%
    Return on Capital Employed
    -100.3%
    Return on Tangible Assets
    -79.4%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -3.4%
    Revenue CAGR 5Y
    -3.5%
    Revenue CAGR 10Y
    31.3%
    EPS CAGR 3Y
    139.7%
    EPS CAGR 5Y
    55.7%
    EPS CAGR 10Y
    18.4%
    FCF CAGR 3Y
    79.2%
    FCF CAGR 5Y
    44.0%
    FCF CAGR 10Y
    6.6%

    Analyst Forecasts

    Analyst Rating
    Hold
    Analyst Count
    2
    EPS Growth Next 3Y
    81.1%
    Revenue Growth Next 3Y
    123.8%
    Earnings Date
    Nov 11, 2026
    EPS Estimate (next Q)
    -$0.13
    EPS Growth Est (next Q)
    -58.5%
    Revenue Est (next Q)
    $800K
    Revenue Growth Est (next Q)
    -76.8%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $13.00
    Price Target Upside
    62.3%

    Cash Flow

    Operating Cash Flow
    $-21.9M
    Free Cash Flow
    $-21.9M
    Adj. Free Cash Flow
    $-25.78M
    FCF Per Share
    -$1.46
    OCF Per Share
    -$1.46
    OCF/S Ratio
    -353.5%

    Income Statement

    Revenue
    $6.19M
    Gross Profit
    $5.66M
    Operating Income
    $-14.23M
    EBITDA
    $-13.65M
    Net Income
    $-16.69M
    EPS (Diluted)
    -$1.18
    Revenue / Employee
    $619.4K
    Profit / Employee
    $-1.67M
    Employees
    10

    © 2026 bestshares.com. All rights reserved.

    All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.